91 related articles for article (PubMed ID: 28830457)
1. Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Guzman J; Kerr T; Ward LM; Ma J; Oen K; Rosenberg AM; Feldman BM; Boire G; Houghton K; Dancey P; Scuccimarri R; Bruns A; Huber AM; Watanabe Duffy K; Shiff NJ; Berard RA; Levy DM; Stringer E; Morishita K; Johnson N; Cabral DA; Larché M; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey SE; Roth J; Campillo S; Benseler S; Chédeville G; Schneider R; Tse SML; Bolaria R; Gross K; Feldman D; Cameron B; Jurencak R; Dorval J; LeBlanc C; St Cyr C; Gibbon M; Yeung RSM; Duffy CM; Tucker LB
Pediatr Rheumatol Online J; 2017 Aug; 15(1):68. PubMed ID: 28830457
[TBL] [Abstract][Full Text] [Related]
2. Identifying factors associated with substantially reduced adult height in patients with juvenile idiopathic arthritis: a retrospective cohort study.
Chen HY; Hu YC; Yang YH; Chiang BL
BMC Pediatr; 2024 May; 24(1):375. PubMed ID: 38816849
[TBL] [Abstract][Full Text] [Related]
3. Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
McGrath T; Guzman J; Tucker L; Shiff NJ; Yaskina M; Tupper S; Rumsey DG;
Pediatr Rheumatol Online J; 2023 Sep; 21(1):102. PubMed ID: 37715224
[TBL] [Abstract][Full Text] [Related]
4. Are the nutritional status and growth parameters of children with juvenile idiopathic arthritis akin to their healthy peers? A single-center experience.
Akgün Ö; Eliuz Tipici B; Kahraman IG; Guliyeva V; Demirkan FG; Tuğrul Aksakal MZ; Aktay Ayaz N
Nutrition; 2024 Aug; 124():112439. PubMed ID: 38669828
[TBL] [Abstract][Full Text] [Related]
5. Growth status and related medical conditions among refugee children in Massachusetts, 1995-1998.
Geltman PL; Radin M; Zhang Z; Cochran J; Meyers AF
Am J Public Health; 2001 Nov; 91(11):1800-5. PubMed ID: 11684607
[TBL] [Abstract][Full Text] [Related]
6. A decade of progress in juvenile idiopathic athritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Nguyen K; Barsalou J; Basodan D; Batthish M; Benseler SM; Berard RA; Blanchette N; Boire G; Bolaria R; Bruns A; Cabral DA; Cameron B; Campillo S; Cellucci T; Chan M; Chédeville G; Chetaille AL; Chhabra A; Couture J; Dancey P; De Bruycker JJ; Demirkaya E; Dhalla M; Duffy CM; Feldman BM; Feldman DE; Gerschman T; Haddad E; Heale L; Herrington J; Houghton K; Huber AM; Human A; Johnson N; Jurencak R; Lang B; Larché M; Laxer RM; LeBlanc CM; Lee JJY; Levy DM; Lim L; Lim LSH; Luca N; McGrath T; McMillan T; Miettunen PM; Morishita KA; Ng HY; Oen K; Park J; Petty RE; Proulx-Gauthier JP; Ramsey S; Roth J; Rosenberg AM; Rozenblyum E; Rumsey DG; Schmeling H; Schneider R; Scuccimarri R; Shiff NJ; Silverman E; Soon G; Spiegel L; Stringer E; Tam H; Tse SM; Tucker L; Turvey S; Twilt M; Duffy KW; Yeung RSM; Guzman J;
Rheumatology (Oxford); 2023 Oct; ():. PubMed ID: 37851400
[TBL] [Abstract][Full Text] [Related]
7. Impact of childhood nephrotic syndrome on obesity and growth: a prospective cohort study.
Robinson CH; Aman N; Banh T; Brooke J; Chanchlani R; Dhillon V; Langlois V; Levin L; Licht C; McKay A; Noone D; Parikh A; Pearl R; Radhakrishnan S; Rowley V; Teoh CW; Vasilevska-Ristovska J; Parekh RS
Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38637343
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for insufficient weight and height gain in children with congenital heart disease followed up at a nutrition outpatient clinic.
Talassi BC; Konstantyner T; Miranda SA; Leite HP
Rev Paul Pediatr; 2022; 40():e2020512. PubMed ID: 35648983
[TBL] [Abstract][Full Text] [Related]
9. Correction to: A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38145453
[No Abstract] [Full Text] [Related]
10. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort.
Shiff NJ; Tupper S; Oen K; Guzman J; Lim H; Lee CH; Bryce R; Huber AM; Boire G; Dancey P; Feldman B; Laxer R; Miettunen P; Schmeling H; Watanabe Duffy K; Levy DM; Turvey S; Bolaria R; Bruns A; Cabral DA; Campillo S; Chédeville G; Feldman DE; Haddad E; Houghton K; Johnson N; Jurencak R; Lang B; Larche M; Morishita K; Ramsey S; Roth J; Schneider R; Scuccimarri R; Spiegel L; Stringer E; Tse SM; Yeung R; Duffy CM; Tucker LB
Pain; 2018 Jan; 159(1):57-66. PubMed ID: 28937578
[TBL] [Abstract][Full Text] [Related]
11. Comics as an educational tool for children with juvenile idiopathic arthritis.
Mendelson A; Rabinowicz N; Reis Y; Amarilyo G; Harel L; Hashkes PJ; Uziel Y
Pediatr Rheumatol Online J; 2017 Sep; 15(1):69. PubMed ID: 28865469
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan AV; Dick AD; Beresford MW
N Engl J Med; 2017 Aug; 377(8):789-790. PubMed ID: 28834482
[No Abstract] [Full Text] [Related]
13. Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry.
Rahman P; Zummer M; Bessette L; Baer P; Haraoui B; Chow A; Kelsall J; Kapur S; Rampakakis E; Psaradellis E; Lehman AJ; Nantel F; Osborne B; Tkaczyk C
BMJ Open; 2017 Aug; 7(8):e016619. PubMed ID: 28855200
[TBL] [Abstract][Full Text] [Related]
14. Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
Lau CS; Gibofsky A; Damjanov N; Lula S; Marshall L; Jones H; Emery P
Rheumatol Int; 2017 Nov; 37(11):1789-1798. PubMed ID: 28852832
[TBL] [Abstract][Full Text] [Related]
15. Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.
Murdaca G; Negrini S; Magnani O; Penza E; Pellecchio M; Gulli R; Mandich P; Puppo F
Mod Rheumatol; 2018 May; 28(3):417-431. PubMed ID: 28837372
[TBL] [Abstract][Full Text] [Related]
16. Radiographic Progression in Psoriatic Arthritis Achieving a Good Response to Treatment: Data Using Newer Composite Indices of Disease Activity.
Helliwell PS; Kavanaugh A
Arthritis Care Res (Hoboken); 2018 May; 70(5):797-800. PubMed ID: 28834259
[TBL] [Abstract][Full Text] [Related]
17. Erratum: How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition.
Ann Rheum Dis; 2017 Oct; 76(10):1783-1784. PubMed ID: 28916663
[No Abstract] [Full Text] [Related]
18. The Implications of Recent Recommendations for Managing Patients with Psoriasis Treated with Fumaric Acid Esters.
Foley CC; Molloy OE; Lally A; Kirby B
Dermatology; 2017; 233(2-3):175-177. PubMed ID: 28869956
[TBL] [Abstract][Full Text] [Related]
19. Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
Rezaei E; Newkirk MM; Li Z; Gordon JR; Oen KG; Benseler SM; Boire G; Cabral DA; Campillo S; Chédeville G; Chetaille AL; Dancey P; Duffy C; Duffy KW; Houghton K; Huber AM; Jurencak R; Lang B; Morishita KA; Petty RE; Ramsey SE; Roth J; Schneider R; Scuccimarri R; Spiegel L; Stringer E; Tse SML; Tucker LB; Turvey SE; Yeung RSM; Rosenberg AM;
J Rheumatol; 2021 May; 48(5):760-766. PubMed ID: 33060303
[TBL] [Abstract][Full Text] [Related]
20. New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
Brunner HI; Schanberg LE; Kimura Y; Dennos A; Co DO; Colbert RA; Fuhlbrigge RC; Goldmuntz E; Kingsbury DJ; Patty-Resk C; Mintz S; Onel K; Rider LG; Schneider R; Watts A; von Scheven E; Lovell DJ; Beukelman T;
Arthritis Rheumatol; 2020 Nov; 72(11):1945-1951. PubMed ID: 32524767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
